GREB1 and breast cancer: GREB1, in combination with other genes, also predicted recurrence of tamoxifen-treated breast cancer [23], as results confirmed in vitro as tamoxifen-resistant breast cancer cells showed a decrease in GREB1 expression while reestablishing GREB1 expression recovered sensitivity to tamoxifen [24].